Press Release: Shuwen : Shuwen Biotech Announces Inclusion of Proprietary Biomarker of Preeclampsia into Clinical Practice Consensus

Shuwen Biotech Announces Inclusion of Proprietary Biomarker of Preeclampsia into Clinical Practice Consensus DEQING, CHINA, March 10, 2021 /⁨EINPresswire.com⁩/ -- Shuwen Biotech, a China-based integrated in vitro diagnostics company, today announced that ...